Rationale and design of a clinical trial of a low-molecular-weight heparin in preventing clincally important venous thromboembolis in medical patients: the Prospective Evaluation of Dalteparin Efficacy for Prevention of Venous Thromboembolism in Immobilized Patients Trial (the PREVENT study)
Rationale and design of a clinical trial of a low-molecular-weight heparin in preventing clincally important venous thromboembolis in medical patients: the Prospective Evaluation of Dalteparin Efficacy for Prevention of Venous Thromboembolism in Immobilized Patients Trial (the PREVENT study). Vascular Medicine. 2002; 7:269-73.